filmov
tv
David's Polycythemia Vera Story: Maintaining a Healthy Lifestyle
Показать описание
David is an MPN Peer within the CHAMPN Connections program living with polycythemia vera (PV). After speaking with his doctor, he adopted a healthy lifestyle of exercising and eating a well-balanced diet since his diagnosis. Connect with David or another MPN Peer to share stories with someone who understands the PV journey. Register now.
0:03:10
The stories behind the advances in polycythemia vera
0:03:02
MPN Hero David Wallace Empowers Patients by Providing Valuable Information Online
0:01:28
Living With Polycythemia Vera (PV)
0:02:55
MPN Hero Patricia Koenig Shares Inspiration and Courage While Living with Polycythemia Vera (PV)
0:05:18
Discover the moment that defined Karen’s journey with polycythemia vera (PV)
0:03:34
Taking Charge of Her Polycythemia Vera: Aimee’s Journey With PV
0:00:44
Blood Cancer UK: Drug for polycythaemia vera approved!
0:03:21
Living With an MPN and Being Your Own Best Advocate
0:27:23
Interactive Case: JAK Inhibitors for the Successful Management of Polycythemia Vera
0:04:29
Laboratory Monitoring for Polycythemia Vera
0:36:00
PV Pod: Stories from the Marrow | What We’ve Learned So Far About Polycythemia Vera
0:02:03
MYELOPROLIFERATIVE NEOPLASMS: What’s happening inside the body
0:11:20
Damage done by the MPN Polycythemia Vera Complications Liver Health😬
0:02:58
Patients reportedly beating cancer with just one tablet a day | 9 News Australia
0:24:12
Debate: Survival benefit of JAK2 inhibitors in Myelofibrosis
0:18:27
Getting Diagnosed with a Rare Cancer: Myelofibrosis | Mary’s Story | The Patient Story
0:05:16
Marilyn’s MPN Story: The Importance of Finding Trust and Building Support
0:00:55
The effect of vorinostat on methylation age in MPN patients
0:04:49
Jim’s MPN Story
0:08:25
Partnering With Your MPN Care Team
0:15:03
Dr. Michael Grunwald ASH 2018 interview with David Wallace, PV Reporter
0:04:36
Being Marilyn…With Myelofibrosis—An MF Journey
0:15:55
Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - Yes
0:06:12
Case 4: The Importance of Early Intervention in MPN
Комментарии